Front Page › Archive › Topic
34 stories on this topic.
Connecticut CannaTimes is hoping to connect with Derrick Gibbs of Budr Cannabis, Jocelyn Cerda of Shangri-La CT, and other social equity owners, equity joint venture partners, cannabis business operators, and individuals with firsthand experience navigating Connecticut’s licensed cannabis market.
A formal petition submitted to Connecticut’s Department of Consumer Protection (DCP) is calling for greater transparency in cannabis safety testing, expanded access to laboratory results, and stronger independent oversight of medical cannabis products.
A federal lawsuit challenging Connecticut’s cannabis social equity licensing system is moving into another round of litigation, with a new court conference scheduled for October 22.
Cannabis consumers are not exactly famously known for driving into Connecticut to buy better cannabis….
DCP records show the Governor’s Office was “primarily responsible for negotiating” an agreement that created a separately regulated tribal cannabis market connected directly to Connecticut’s existing industry.
Editor’s Note / Correction: Connecticut CannaTimes published an article on September 23 detailing Connecticut’s little-publicized state cannabis testing program at the Connecticut Agricultural Experiment Station, or CAES, and the state’s expansion into microbiological reference testing.
State records show Connecticut has operated a government cannabis testing program for years, tested more than 265 samples submitted by regulators, and planned its laboratory as an oversight operation for private cannabis labs. Now the state is adding microbiological testing for mold, Aspergillus and other pathogens using qPCR.
A federal judge dismissed a constitutional challenge to Connecticut’s cannabis licensing system this week, but not because the court found the state’s social equity rules constitutional. The ruling instead identifies shortcomings in the plaintiff’s case and leaves the door open for an amended complaint. It also raises an important question: Are there cannabis entrepreneurs who
That is the sentence imposed in a Connecticut criminal case involving psilocybin mushrooms and an alleged large-scale operation producing psilocybin and THC products.
Connecticut cannabis consumers are routinely told two numbers: adults may possess 1.5 ounces of cannabis in public and up to 5 ounces in a locked container at home.
When former State Representative Brandon McGee became Executive Director of Connecticut’s Social Equity Council in August 2024, he inherited an agency at a turning point.
Connecticut Opened a New Cannabis Lane While Its Existing Market Came Under Constitutional Fire - Pequot Compact / Smith vs Lamont
A routine Connecticut Social Equity Council meeting took an unexpected turn on May 5 when a discussion about liability protections, legal disclaimers, and loan programs evolved into a public disagreement over the relationship between Council members and agency staff.
The phrase “fentanyl-laced cannabis” is frightening because fentanyl is frightening. Nobody serious should minimize fentanyl. It is potent, dangerous, and responsible for mass overdose deaths across the country.
As Connecticut prepares to distribute millions of dollars in cannabis tax revenue through the Social Equity Council’s Reimagine & Revitalize (R2) Community Reinvestment Program, an uncomfortable question is emerging:
When Connecticut legalized cannabis, lawmakers made a promise.
CT CannaTimes is seeking information from patients and consumers who may have purchased or consumed the cannabis flower product identified as 5EPU33-SC (Permanent Urkel). A review of laboratory records provided to CT CannaTimes shows what appears to be a significant discrepancy between two Certificates of Analysis (COAs) associated with the same product identifier.
CT CannaTimes is seeking information from Connecticut cannabis patients and consumers regarding a Brix Cannabis flower product identified during a review of Connecticut cannabis testing records.
Original reporting referenced from CT Insider by Jordan Nathaniel Fenster. Additional analysis and commentary by CT CannaTimes.
The Connecticut legislative session may be over, but the decisions made this year are going to shape the state’s cannabis market for years and now the Social Equity Council is once again allowing public comment at meetings.
Connecticut officials keep acting like consumer freedom is the problem with the cannabis market.
Connecticut consumers are being told that Mike Tyson’s cannabis brand is officially coming to the state through Rodeo Cannabis in Rocky Hill.
CT CannaTimes would like to thank the bipartisan proponents, sponsors, and supporters of SB 191 “An Act Concerning the Psychedelic-Assisted Therapy Pilot Program” which officially passed both chambers of the Connecticut General Assembly today.
Buried inside HB 5222 is a little-noticed cannabis definition rewrite that could have major consequences for Connecticut’s hemp and cannabinoid market.
Dabbin’ Dad needs to explain its position.
A federal investigation into the collapse of a Hartford nonprofit is raising new oversight questions that now sit uncomfortably close to Connecticut’s cannabis social equity system.
That is the date the United States government was granted U.S. Patent No. 6,630,507 for cannabinoids, formally recognizing them as compounds with medical value, including antioxidant and neuroprotective properties with potential applications in conditions such as Alzheimer’s disease, Parkinson’s disease, and stroke.
Hartford, CT — A provision in the amended version of House Bill 5350 creates a clear pathway for Social Equity cannabis businesses in Connecticut to be sold or transferred after a set period; while requiring a fixed state fee each time ownership changes.
HARTFORD — In a stunning contradiction, Connecticut lawmakers have passed House Bill 5350 after floor debate repeatedly emphasizing that legal cannabis is “safe because it is tested” while the bill itself strips those testing standards out of state statute.
The Connecticut Department of Consumer Protection has brought a sweeping enforcement action against Rino Ferrarese and his company, Affinity Grow.
Three dispensary entities connected to the same business structure made coordinated payments into leadership PAC.
Video Source Credit: NBC News Connecticut (No Affiliation, CT CannaTimes views are our own.)
Connecticut lawmakers had two paths in front of them this year.
All data sourced from the Connecticut eLicense Lookup – verifiable public record (https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx)
